Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CYP3A4 Induction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00608907
What this trial is testing

An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)

Who this might be right for
Multiple MyelomaNon-Hodgkin's Lymphoma
Millennium Pharmaceuticals, Inc. 61
Early research (Phase 1)Study completedNCT05694533
What this trial is testing

Study of Potential CYP3A4 Induction by INDV-2000 in Healthy Adults

Who this might be right for
Healthy
Indivior Inc. 20
Not applicableStudy completedNCT02428660
What this trial is testing

Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM

Who this might be right for
Cytochrome P450 CYP2D6 Enzyme DeficiencyPoor Metabolizer Due to Cytochrome P450 CYP2D6 VariantUltrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant+6 more
Genelex Corporation 341
Early research (Phase 1)Study completedNCT05530278
What this trial is testing

Assess the Pharmacokinetics and Safety of Co-administered Oral Galicaftor, Navocaftor, and ABBV-576 in Healthy Adults for the Treatment of Cystic Fibrosis

Who this might be right for
Healthy Volunteers
AbbVie 24
Early research (Phase 1)Study completedNCT02199392
What this trial is testing

A Pharmacokinetic Study to Assess the Influence of P-glycoprotein Inhibition and Simultaneous CYP3A4 and P-glycoprotein Induction on E7080 Pharmacokinetics Following Single Dose Oral Administration of 24 mg E7080 to Healthy Volunteers

Who this might be right for
P-glycoproteinHealthy Volunteers
Eisai Inc. 15
Early research (Phase 1)Study completedNCT05526911
What this trial is testing

A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults

Who this might be right for
Pulmonary DiseaseTuberculosis, PulmonaryTuberculosis+4 more
Global Alliance for TB Drug Development 28
Early research (Phase 1)Study completedNCT04027192
What this trial is testing

Study to Test the Safety of Increasing Multiple Doses of BAY2328065 Given by Mouth, How the Drug is Tolerated and Acts in the Human Body of Healthy Male Participants. Alteration of the Study Drug Effects by Another Drug and the Availability of the Drug Given in Different Formulations is Also Tested.

Who this might be right for
Endometriosis
Bayer 50
Early research (Phase 1)Study completedNCT04290390
What this trial is testing

Annovera™ Drug-Drug Interaction Study

Who this might be right for
WomenContraception
TherapeuticsMD 67
Early research (Phase 1)Study completedNCT03058419
What this trial is testing

Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects

Who this might be right for
Healthy
Janssen Research & Development, LLC 16
Post-approval studies (Phase 4)Study completedNCT00006395
What this trial is testing

Drug Interaction Study of Tegretol (Carbamazepine) and St. John's Wort in Normal Volunteers

Who this might be right for
Healthy
National Institutes of Health Clinical Center (CC) 12
Early research (Phase 1)Study completedNCT07259330
What this trial is testing

To Determine the Effect of CYP Induction Following Administration of Nirogacestat in Healthy Adult Male Participants

Who this might be right for
Healthy
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 20
Not applicableStudy completedNCT02629770
What this trial is testing

Clindamycin-rifampin Drug Interaction in the Treatment of Bone and Joint Infections

Who this might be right for
Arthritis, InfectiousBone Diseases, Infectious
Groupe Hospitalier Diaconesses Croix Saint-Simon 49
Not applicableStudy completedNCT01340456
What this trial is testing

Cholesterol Metabolites as Markers for CYP3A Induction

Who this might be right for
CYP3A4 Induction
Karolinska University Hospital 24
Post-approval studies (Phase 4)Study completedNCT00260247
What this trial is testing

Induction of Drug Metabolism: In Vivo Comparison of Carbamazepine and Oxcarbazepine.

Who this might be right for
Metabolic Clearance Rate
Odense University Hospital 10
Early research (Phase 1)Study completedNCT00511823
What this trial is testing

The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects

Who this might be right for
Nausea and Vomiting, Chemotherapy-Induced
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT04166669
What this trial is testing

A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001

Who this might be right for
Fungal Infection
Basilea Pharmaceutica 36
Early research (Phase 1)UnknownNCT06379958
What this trial is testing

Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects

Who this might be right for
Pharmacokinetics
Modern Biosciences Ltd 48
Early research (Phase 1)Study completedNCT02256267
What this trial is testing

LY2835219 in Healthy Participants

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 24
Early research (Phase 1)WithdrawnNCT01981486
What this trial is testing

The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy Adults

Who this might be right for
Migraine
Pfizer
Early research (Phase 1)Study completedNCT03048110
What this trial is testing

Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction

Who this might be right for
Biological Availability
Bayer 15
Next Page